Cell and Gene Therapy Supply Chain Software Market Estimated to Experience a Hike in Growth by 2035
Roots Analysis recently published a report on the global Cell and Gene Therapy Supply Chain Software Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.

Market Size and Forecast

Current Market Size:USD 356 million

Future Market Size: USD 1,329 million

CAGR: 15.8%

Market Overview

This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.

This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.

Market Scope and Segmentation

– Historical Trend: Since 2019
– Base Year: 2023
– Forecast Period: Till 2035
– Market Size 2026: USD 356 million
– Market Size 2035: USD 1,329 million
– CAGR (Till 2035): 15.8%
– Process Component
• Sample Collection and Processing Component
• Manufacturing Component
• Logistics Component
• Patient Identification and Treatment Follow-up Component
– Type of Software
• Enterprise Manufacturing System (EMS)
• Laboratory Information Management System (LIMS)
• Inventory Management System (IMS)
• Cell Orchestration Platform (COP)
• Quality Management System (QMS)
• Logistics Management System (LMS)
• Patient Management System (PMS)
– Mode of Deployment
• On-premises Deployment
• Cloud-based Deployment
– Type of End-User
• Pharmaceutical Companies
• Cell Therapy Labs
• Hospitals / Medical Centers
• Research Institutes / Biobanks
– Scale of Operation
• Clinical Scale
• Commercial Scale
– Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World
– Key Companies Profiled
• Azenta Life Sciences
• Biocair
• BioLife Solutions
• CareDx
• Cryoport
• Lonza
• NMDP BioTherapies
• TraceLink
• TrakCel
• Veeva Systems
• Emerson
• LabVantage Solutions
• Marken
• MasterControl
• QuickSTAT
• Siemens
• Stafa Cellular Therapy
• Steiner
• STEMSOFT Software
• TECHNIDATA
• Thermo Fisher Scientific
– PowerPoint Presentation(Complimentary): Available
– Customization scope: 15% Free Customization
– Excel Data Packs (Complimentary)
• Market Landscape Analysis
• Company Competitiveness Analysis
• Funding and Investment Analysis
• Partnership and Collaborations Analysis
• Platform Utilization Cases Analysis
• Market Size an Opportunity Analysis

Read More: https://www.rootsanalysis.com/reports/cell-therapies-supply-chain/260.html

By Region

This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities.

Technological and Strategic Insights

The Roots Analysis report includes a detailed assessment of:

Technological advancements and R&D activity
Innovations in formulation and delivery methods
Marketing and distribution strategies
Pricing models and cost structures
Manufacturing capacities and supply chain trends
These insights are presented neutrally, supported by empirical evidence and primary research validation.

Key Market Players

Profiles of prominent companies include:

Azenta Life Sciences, Biocair, BioLife Solutions, CareDx, Cryoport, Lonza, NMDP BioTherapies, TraceLink, TrakCel, Veeva Systems, Emerson, LabVantage Solutions, Marken, MasterControl, QuickSTAT, Siemens, Stafa Cellular Therapy, Steiner, STEMSOFT Software, TECHNIDATA, Thermo Fisher Scientific

Each profile highlights:

Product portfolio and focus areas
Operational footprint and regional presence
Financial and strategic performance
Recent developments (e.g., partnerships, market entries, acquisitions)
Regional Insights

Each region is analyzed based on:

Historical and current market size
Revenue performance
Contribution to global share
Strategic developments and regional trends
Comparative insights across regions enable targeted market entry and expansion strategies.

Report Structure

Part 01: Market Overview
Part 02: Market Size, by Regions
Part 03: Market Revenue, by Countries
Part 04: Market Competition, by Key Players
Part 05: Company Profiles